Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations occur in up to 50% of Asian patients with non-small cell lung cancer (NSCLC). Treatment of advanced NSCLC patients with EGFR-tyrosine kinase inhibitor (EGFR-TKI) confers a significant survival benefit. This study assessed the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Siyang, Wang, Yuanyuan, Cai, Kaican, Wu, Hua, Xiong, Gang, Wang, Haofei, Zhang, Ziliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608803/
https://www.ncbi.nlm.nih.gov/pubmed/26474174
http://dx.doi.org/10.1371/journal.pone.0140794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608803/
https://www.ncbi.nlm.nih.gov/pubmed/26474174
http://dx.doi.org/10.1371/journal.pone.0140794

Ejemplares similares